Light Mode
$45.36 ↓ -0.22 (-0.48%) Trading Down from the previous close of $45.58, $0.71 below the day’s high of $46.07
-14.26 (-23.79%) / 6M
Momentum, market sentiment, and recent alerts
BSX reads neutral: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is -55.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.